Memory and flexibility of cytokine gene expression as separable properties of human TH1 and TH2 lymphocytes

Nature Immunology

Volumn 4, Issue 1, 2003, Pages 78-86

  Messi, Mara ^a   Giacchetto, Isabella ^a   Nagata, Kinya ^b   Lanzavecchia, Antonio ^a   Natoli, Giocchino ^a   Sallusto, Federica ^a  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^b BML   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HISTONE;

ACETYLATION; CELL STIMULATION; CONTROLLED STUDY; EFFECTOR CELL; GENE EXPRESSION; GENE SILENCING; HUMAN; IMMUNOLOGICAL MEMORY; LYMPHOCYTE FUNCTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; TH1 CELL; TH2 CELL;

ACETYLATION; BASE SEQUENCE; CELL LINE; CYTOKINES; DNA; DNA-BINDING PROTEINS; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION; HISTONES; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; INTERLEUKIN-4; PROMOTER REGIONS (GENETICS); T-BOX DOMAIN PROTEINS; TH1 CELLS; TH2 CELLS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0037236203     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni872     Document Type: Review

References (63)

1. Paul, W.E. & Seder, R.A. Lymphocyte responses and cytokines. Cell 76, 241-251 (1994).
2. Romagnani, S. The Th1/Th2 paradigm. Immunol. Today 18, 263-266 (1997).
3. H2 development. Nat. Immunol. 1, 199-205 (2000).
4. Sallusto, F., Mackay, C.R. & Lanzavecchia, A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18, 593-620 (2000).
5. Campbell, J.J. & Butcher, E.C. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol. 12, 336-341 (2000).
6. Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708-712 (1999).
7. Lanzavecchia, A. & Sallusto, F. Dynamics of T lymphocyte responses: intermediates, effectors and memory cells. Science 290, 92-97 (2000).
8. Kim, C.H., Campbell, D.J. & Butcher, E.C. Nonpolarized memory T cells. Trends Immunol. 22, 527-530 (2001).
9. Sad, S. & Mosmann, T.R. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol. 153, 3514-3522 (1994).
10. Sallusto, F., Lenig, D., Mackay, C.R. & Lanzavecchia, A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187, 875-883 (1998).
11. Iezzi, G., Scotet, E., Scheidegger, D. & Lanzavecchia, A. The interplay between the duration of TCR and cytokine signalling determines T cell polarization. Eur. J. Immunol. 29, 4092-4101 (1999).
12. H2 and nonpolarized T cells. Nat. Immunol. 1, 311-316 (2000).
13. Reinhardt, R.L., Khoruts, A., Merica, R., Zell, T. & Jenkins, M.K. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410, 101-105 (2001).
14. Wang, X. & Mosmann, T. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-γ, and can subsequently differentiate into IL-4- or IFN-γ-secreting cells. J. Exp. Med. 194, 1069-1080 (2001).
15. Lauvau, G. et al. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 294, 1735-1739 (2001).
16. Masopust, D., Vezys, V., Marzo, A.L. & Lefrancois, L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291, 2413-2417 (2001).
17. Champagne, P. et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410, 106-111 (2001).
18. + T cell responses from primary to persistent phases of Epstein-Barr virus infection. J. Exp. Med. 195, 893-905 (2002).
19. Murphy, K.M. et al. Signaling and transcription in T helper development. Annu. Rev. Immunol. 18, 451-494 (2000).
20. Glimcher, L.H. & Murphy, K.M. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev. 14, 1693-1711 (2000).
21. Reiner, S.L. Helper T cell differentiation, inside and out. Curr. Opin. Immunol. 13, 351-355 (2001).
22. Ho, I.C. & Glimcher, L.H. Transcription: tantalizing times for T cells. Cell 109 (Suppl.) 109-120 (2002).
23. Rao, A. & Avni, O. Molecular aspects of T-cell differentiation. Br. Med. Bull. 56, 969-984 (2000).
24. Szabo, S.J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669 (2000).
25. HI cells before IL-12-dependent selection. Science 292, 1907-1910 (2001).
26. + T cells. Nat. Immunol. 13, 549-557 (2002).
27. HI lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295, 338-342 (2002).
28. Zheng, W. & Flavell, R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587-596 (1997).
29. Ho, I.C., Hodge, M.R.. Rooney, J.W. & Glimcher, L.H. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85, 973-983 (1996).
30. Agarwal, S. & Rao, A. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9, 765-775 (1998).
31. Takemoto, N. et al. Cutting edge: chromatin remodeling at the IL-4/IL-13 intergenic regulatory region for Th2-specific cytokine gene cluster. J. Immunol. 165, 6687-6691 (2000).
32. Lee, G.R., Fields, P.E. & Flavell, R.A. Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity 14, 447-459 (2001).
33. Agarwal, S., Avni, O. & Rao, A. Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo. Immunity 12, 643-652 (2000).
34. Mohrs, M. et al. Deletion of a coordinate regulator of type 2 cytokine expression in mice. Nat. Immunol. 2, 842-847 (2001).
35. Kim, J.I., Ho, I.C., Grusby, M.J. & Glimcher, L.H. The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity 10, 745-751 (1999).
36. Szabo, S.J., Dighe, A.S., Gubler, U. & Murphy, K.M. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper I (Th1) and Th2 cells. J. Exp. Med. 185, 817-824 (1997)
37. Rogge, L. et al. Selective expression of an interleukin-12 receptor component by human T helper I cells. J. Exp. Med. 185, 825-831 (1997).
38. Grogan, J.L. et al. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14, 205-215 (2001).
39. + T cell clones. J. Immunol. 141, 849-855 (1988).
40. Openshaw, P. et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper I and T helper 2 populations. J. Exp. Med. 182, 1357-1367 (1995).
41. Smale, S.T. & Fisher, A.G. Chromatin structure and gene regulation in the immune system. Annu. Rev. Immunol. 20, 427-462 (2002).
42. Tse, C., Sera, T., Wolffe, A.P. & Hansen, J.C. Disruption of higher-order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol. Cell Biol. 18, 4629-4638 (1998).
43. Lee, D.Y., Hayes, J.J., Pruss, D. & Wolffe, A.P. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72, 73-84 (1993).
44. Vettese-Dadey, M. et al. Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. EMBO J. 15, 2508-2518 (1996).
45. Vitolo, J.M., Thiriet, C. & Hayes, J.J. The H3-H4 N-terminal tail domains are the primary mediators of transcription factor IIIA access to 5S DNA within a nucleosome. Mol. Cell Biol. 20, 2167-2175 (2000).
46. Dhalluin, C. et al. Structure and ligand of a histone acetyltransferase bromodomain. Nature 399, 491-496 (1999).
47. Jacobson, R.H., Ladurner, A.G., King, D.S. & Tjian, R. Structure and function of a human TAF11250 double bromodomain module. Science 288, 1422-1425 (2000).
48. Ekwall, K., Olsson, T., Turner, B.M., Cranston, G. & Allshire, R.C. Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres. Cell 91, 1021-1032 (1997).
49. Cavalli, G. & Paro, R. Epigenetic inheritance of active chromatin after removal of the main transactivator. Science 286, 955-958 (1999).
50. H cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat. Immunol. 10, 643-651 (2002).
51. Fields, P.E., Kim, S.T. & Flavell, R.A. Cutting edge: changes in histone acetylation at the IL-4 and IFN-γ loci accompany Th1/Th2 differentiation. J. Immunol. 169, 647-650 (2002).
52. Loetscher, P. et al. CCR5 is characteristic of Th1 lymphocytes. Nature 391, 344-345 (1998).
53. Bonecchi, R. et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187, 129-134 (1998).
54. Nagata, K. et al. Selective expression of a novel surface molecule by human Th2 cells in vivo. J. Immunol. 162, 1278-1286 (1999).
55. Cosmi, L. et al. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur. J. Immunol. 30, 2972-2979 (2000).
56. + T cells acts in an autocrine manner to induce Th2 differentiation. Eur. J. Immunol. 32, 1428-1433 (2002).
57. Jenuwein, T. & Allis, C.D. Translating the histone code. Science 293, 1074-1080 (2001).
58. Murphy, E. et al. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183, 901-913 (1996).
59. Smits, H.H. et al. IL-12-induced reversal of human Th2 cells is accompanied by full restoration of IL-12 responsiveness and loss of GATA-3 expression. Eur. J. Immunol. 31, 1055-1065 (2001).
60. Iwasaki, M. et al. Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. J. Invest Derm. 119, 609-616 (2002).
61. H2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide. J. Allergy Clin. Immunol. 108, 815-821 (2001).
62. Breitfeld, D. et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192, 1545-1552 (2000).
63. Kim, C.H. et al. Rules of chemokine receptor association with T cell polarization in vivo. J. Clin. Invest. 108, 1331-1339 (2001).